{"id":"https://openalex.org/W4389247264","doi":"https://doi.org/10.1182/blood-2023-190327","title":"STAG2 loss Induces HSC Programs By Modulating Accessibility of AP-1 Bound Enhancers","display_name":"STAG2 loss Induces HSC Programs By Modulating Accessibility of AP-1 Bound Enhancers","publication_year":2023,"publication_date":"2023-11-02","ids":{"openalex":"https://openalex.org/W4389247264","doi":"https://doi.org/10.1182/blood-2023-190327"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2023-190327","doi":"https://doi.org/10.1182/blood-2023-190327","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1182/blood-2023-190327","pdf_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/1385/2201321/blood-7988-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/1385/2201321/blood-7988-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068740542","display_name":"Amy Wang","orcid":"https://orcid.org/0000-0002-3816-951X","observed_orcids":["https://orcid.org/0000-0002-3816-951X"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Wang","raw_affiliation_strings":["1Cancer Program, Broad Institute, Cambridge, MA","2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Program, Broad Institute, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100785833","display_name":"Lin Han","orcid":"https://orcid.org/0000-0001-9725-1946","observed_orcids":["https://orcid.org/0000-0001-9725-1946","https://orcid.org/0000-0002-9597-9535"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lin Han","raw_affiliation_strings":["1Cancer Program, Broad Institute, Cambridge, MA","2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Program, Broad Institute, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024722625","display_name":"Benjamin S. Braun","orcid":"https://orcid.org/0000-0002-7363-9185","observed_orcids":["https://orcid.org/0000-0002-7363-9185"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Braun","raw_affiliation_strings":["1Cancer Program, Broad Institute, Cambridge, MA","2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Program, Broad Institute, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052141916","display_name":"Caroline N. Pitton","orcid":"https://orcid.org/0000-0002-6538-4506","observed_orcids":["https://orcid.org/0000-0002-6538-4506"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caroline Pitton","raw_affiliation_strings":["1Cancer Program, Broad Institute, Cambridge, MA","2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Program, Broad Institute, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069339719","display_name":"Johann-Christoph Jann","orcid":"https://orcid.org/0000-0003-2200-0151","observed_orcids":["https://orcid.org/0000-0003-2200-0151"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johann-Christoph Jann","raw_affiliation_strings":["1Cancer Program, Broad Institute, Cambridge, MA","2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Program, Broad Institute, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083543522","display_name":"Zuzana T\u00f3thov\u00e1","orcid":"https://orcid.org/0000-0001-6668-532X","observed_orcids":["https://orcid.org/0000-0001-6668-532X"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zuzana Tothova","raw_affiliation_strings":["1Cancer Program, Broad Institute, Cambridge, MA","2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Program, Broad Institute, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"142","issue":"Supplement 1","first_page":"1385","last_page":"1385"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10222","display_name":"Genomics and Chromatin Dynamics","score":0.7026000022888184,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10222","display_name":"Genomics and Chromatin Dynamics","score":0.7026000022888184,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.16019999980926514,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.11869999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stag2","display_name":"STAG2","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cohesin","display_name":"cohesin","score":0.8489999771118164},{"id":"https://openalex.org/keywords/hematopoietic-stem-cells","display_name":"hematopoietic stem cells","score":0.7820000052452087},{"id":"https://openalex.org/keywords/chromatin-accessibility","display_name":"chromatin accessibility","score":0.7129999995231628},{"id":"https://openalex.org/keywords/enhancer-regulation","display_name":"enhancer regulation","score":0.6710000038146973},{"id":"https://openalex.org/keywords/ap-1-transcription-factor","display_name":"AP-1 transcription factor","score":0.984000027179718},{"id":"https://openalex.org/keywords/c-jun","display_name":"c-Jun","score":0.671999990940094},{"id":"https://openalex.org/keywords/fos","display_name":"FOS","score":0.9760000109672546},{"id":"https://openalex.org/keywords/atf","display_name":"ATF","score":0.8320000171661377},{"id":"https://openalex.org/keywords/c-ebp","display_name":"C/EBP","score":0.9340000152587891},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.8510000109672546},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/clonal-expansion","display_name":"clonal expansion","score":0.8059999942779541},{"id":"https://openalex.org/keywords/u937-cells","display_name":"U937 cells","score":0.6959999799728394},{"id":"https://openalex.org/keywords/histone-modifications","display_name":"histone modifications","score":0.6129999756813049},{"id":"https://openalex.org/keywords/h3k27ac","display_name":"H3K27ac","score":0.8399999737739563}],"concepts":[{"id":"https://openalex.org/C115821613","wikidata":"https://www.wikidata.org/wiki/Q21103063","display_name":"Cohesin","level":4,"score":0.8952409625053406},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.8125272989273071},{"id":"https://openalex.org/C111936080","wikidata":"https://www.wikidata.org/wiki/Q913367","display_name":"Enhancer","level":4,"score":0.657585859298706},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6500252485275269},{"id":"https://openalex.org/C134320426","wikidata":"https://www.wikidata.org/wiki/Q901026","display_name":"Chromatin immunoprecipitation","level":5,"score":0.6418749690055847},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.5239736437797546},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.5072095394134521},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4571206271648407},{"id":"https://openalex.org/C152369539","wikidata":"https://www.wikidata.org/wiki/Q5399999","display_name":"Establishment of sister chromatid cohesion","level":5,"score":0.4549422562122345},{"id":"https://openalex.org/C2778760011","wikidata":"https://www.wikidata.org/wiki/Q21163346","display_name":"CTCF","level":5,"score":0.42818039655685425},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.4240194857120514},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3381173014640808},{"id":"https://openalex.org/C101762097","wikidata":"https://www.wikidata.org/wiki/Q224093","display_name":"Promoter","level":4,"score":0.23824542760849},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20362120866775513},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.15144866704940796}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2023-190327","doi":"https://doi.org/10.1182/blood-2023-190327","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1182/blood-2023-190327","pdf_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/1385/2201321/blood-7988-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2023-190327","doi":"https://doi.org/10.1182/blood-2023-190327","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1182/blood-2023-190327","pdf_url":"https://ashpublications.org/blood/article-pdf/142/Supplement 1/1385/2201321/blood-7988-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389247264.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310161046","https://openalex.org/W2908042210","https://openalex.org/W3014716126","https://openalex.org/W3166119693","https://openalex.org/W4401117745","https://openalex.org/W6969128417","https://openalex.org/W3080481270","https://openalex.org/W4411258293","https://openalex.org/W2733653783","https://openalex.org/W4402483967"],"abstract_inverted_index":{"Myelodysplastic":[0],"syndromes":[1],"(MDS)":[2],"and":[3,19,34,42,75,101,143,149,156,295,316,355,379,442,462,497,507,535,540,568,587],"acute":[4],"myeloid":[5,480,618],"leukemia":[6,105],"(AML)":[7],"are":[8,36,57,622],"blood":[9],"disorders":[10],"characterized":[11],"by":[12,47,218,300,303,446],"clonal":[13,53,435],"expansion":[14,54,436,461],"of":[15,55,72,82,94,111,137,140,178,204,211,230,239,241,284,319,331,349,365,384,414,434,437,455,464,477,510,526,538,553,557,563,575,594,599],"mutant":[16,479,516,601,617],"hematopoietic":[17,420],"stem":[18,421],"progenitor":[20],"cells":[21,262,268],"(HSPCs).":[22],"Mutations":[23],"in":[24,40,91,152,161,174,215,252,258,273,323,346,357,369,376,388,391,396,404,439,459,492,514,533,566,569,597,603,615],"genes":[25,322,457],"encoding":[26],"the":[27,45,80,109,153,162,176,201,223,242,259,301,329,397,405,551,576,612],"cohesin":[28,49,83,141,147,173,616],"complex,":[29],"including":[30,246],"STAG2,":[31],"RAD21,":[32],"SMC3":[33],"SMC1A,":[35],"frequent":[37],"genetic":[38],"drivers":[39],"MDS":[41,366,539,602],"AML.":[43,541],"However,":[44],"mechanisms":[46],"which":[48,129,447,620],"mutations":[50,84],"lead":[51],"to":[52,291,296,473,550],"HSPCs":[56,438],"not":[58],"well":[59],"understood.":[60],"Cohesin":[61],"is":[62,429],"essential":[63],"for":[64,133,172,193,419,611],"sister":[65],"chromatid":[66],"cohesion,":[67],"DNA":[68],"damage":[69],"repair,":[70],"maintenance":[71],"chromatin":[73,86,127,189,277,378,505],"architecture,":[74],"gene":[76,317,423],"regulation.":[77],"To":[78,198,279,341,466],"investigate":[79],"impact":[81],"on":[85],"accessibility,":[87],"we":[88,115,208,287,352,482,544,621],"performed":[89,353,483],"ATAC-Seq":[90,113,356,489],"a":[92,169,309,361,381,444,554,608],"panel":[93],"six":[95],"isogenic":[96],"STAG2":[97,119,163,186,195,260,266,324,527,547],"wild":[98],"type":[99],"(WT)":[100],"knockout":[102,500],"(KO)":[103],"U937":[104,398],"cell":[106,422],"lines.":[107],"Among":[108],"total":[110],"97,798":[112],"peaks,":[114],"identified":[116],"significantly":[117,256],"more":[118],"KO":[120,164,261,267,325],"(8,859)":[121],"versus":[122,407],"WT":[123,408,518],"(1,622)":[124],"uniquely":[125],"accessible":[126,166,334,377,558],"sites,":[128],"were":[130,417,471],"strongly":[131],"enriched":[132,192,257,418,580],"intergenic":[134,389,559],"regions.":[135],"Integration":[136],"ChIP-Seq":[138],"profiling":[139],"binding":[142,148,210,238,272,315,387,416,582],"histone":[144,158],"modifications":[145],"demonstrated":[146,380],"an":[150,374],"increase":[151,375],"active":[154],"enhancer":[155,564],"promoter":[157,293],"mark":[159],"H3K27Ac":[160],"newly":[165,333],"chromatin,":[167],"suggesting":[168],"direct":[170],"role":[171,330,610],"regulating":[175],"activity":[177,565],"such":[179],"enhancers.":[180,197],"Together,":[181,520],"our":[182,343,370,394,432,469],"data":[183,522],"demonstrate":[184,588],"that":[185,237,275,411,546,589],"KO-induced":[187,528],"open":[188],"may":[190,452,591],"be":[191],"novel":[194,448,555],"KO-specific":[196],"further":[199,327,523],"infer":[200],"regulatory":[202,282,339,531],"function":[203],"these":[205,285,332,521,584],"putative":[206,320,412,585],"enhancers,":[207,586],"predicted":[209,313,385,581],"transcription":[212,244],"factors":[213],"(TFs)":[214],"ATAC-Seq-defined":[216],"regions":[217,274,294,560],"performing":[219],"TF":[220,271,289,484],"footprinting":[221,485],"using":[222,345,486],"Transcription":[224],"factor":[225],"Occupancy":[226],"Prediction":[227],"By":[228],"Investigation":[229],"ATAC-seq":[231],"Signal":[232],"(TOBIAS)":[233],"algorithm.":[234],"We":[235,307,372,502,571,605],"observed":[236,308],"members":[240,574],"AP-1":[243,314,335,529,577,590,613],"family,":[245],"JUN":[247],"FOS":[248],"andATF,":[249],"previously":[250,367],"implicated":[251],"oncogenic":[253],"transformation,":[254],"was":[255],"(Figure":[263,425],"1A).":[264],"Conversely,":[265],"lost":[269,276],"CEBP":[270],"accessibility.":[278],"identify":[280,572],"potential":[281,609],"targets":[283,413],"TFs,":[286],"mapped":[288],"footprints":[290,513],"annotated":[292],"enhancer-gene":[297],"pairs":[298],"determined":[299],"Activity":[302],"Contact":[304],"(ABC)":[305],"model.":[306,399],"strong":[310,382],"correlation":[311],"between":[312],"expression":[318,454,593],"regulated":[321],"cells,":[326],"supporting":[328],"bound":[336,450,530],"sites":[337],"as":[338],"elements.":[340],"validate":[342,524],"findings":[344,470],"vivo":[347],"models":[348,476,537,598],"cohesin-mutant":[350],"disease,":[351],"RNA-Seq":[354],"HSPC":[358,409,460,493,595],"isolated":[359,494],"from":[360,495],"Tet2/Stag2":[362],"mouse":[363,536],"model":[364],"developed":[368],"lab.":[371],"confirmed":[373],"enrichment":[383,402,509],"Ap-1":[386,415,449,512],"regions,":[390],"agreement":[392],"with":[393,431,561,579],"observations":[395],"Gene":[400],"set":[401,556],"analysis":[403],"Tet2/Stag2-mutant":[406],"revealed":[410],"signatures":[424,596],"1B)":[426],".":[427],"This":[428],"consistent":[430],"observation":[433],"this":[440],"model,":[441],"suggests":[443],"mechanism":[445],"enhancers":[451],"facilitate":[453],"key":[456],"involved":[458],"development":[463],"MDS/AML.":[465],"explore":[467],"whether":[468],"applicable":[472],"other":[474],"published":[475],"Stag2":[478,496,515,600],"neoplasms,":[481],"publicly":[487],"available":[488],"datasets":[490],"generated":[491],"Runx1/Stag2":[498],"conditional":[499],"mice.":[501],"recapitulated":[503],"increased":[504],"accessibility":[506],"significant":[508],"cohesin-bound":[511],"over":[517],"conditions.":[519],"conservation":[525],"elements":[532],"human":[534],"In":[542],"summary,":[543],"show":[545],"loss":[548],"leads":[549],"establishment":[552],"features":[562],"vitro":[567],"vivo.":[570,604],"multiple":[573],"complex":[578,614],"at":[583],"drive":[592],"illustrate":[606],"here":[607],"malignancies,":[619],"currently":[623],"functionally":[624],"interrogating.":[625]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2023-12-02T00:00:00"}